Sign in

CIK 0001875558 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Nuvectis Pharma, Inc.

Sign in to watch
Ticker
NVCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
862405608
Phone
360-837-7232
Business address
1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 30 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-19 BENTSUR RON Chairman & CEO Purchase +200 $14.33 $3K 3,231,559
2023-07-18 Mosseri Marlio Charles 10% owner Purchase +9,149 $14.84 $136K 2,563,762
2023-07-14 BENTSUR RON Chairman & CEO Purchase +150 $15.03 $2K 3,231,359
2023-07-12 Mosseri Marlio Charles 10% owner Purchase +3,285 $15.09 $50K 2,554,613
2023-07-11 Mosseri Marlio Charles 10% owner Purchase +10,000 $15.36 $154K 2,551,328
2023-07-07 BENTSUR RON Chairman & CEO Purchase +110 $16.19 $2K 3,231,209
2023-07-07 Mosseri Marlio Charles 10% owner Purchase +8,948 $15.19 $136K 2,541,328
2023-07-06 Mosseri Marlio Charles 10% owner Purchase +3,179 $15.01 $48K 2,532,380
2023-07-06 BENTSUR RON Chairman & CEO Purchase +320 $14.88 $5K 3,231,099
2023-07-05 Mosseri Marlio Charles 10% owner Purchase +1,176 $15.52 $18K 2,529,201
2023-06-26 Mosseri Marlio Charles 10% owner Purchase +16,760 $16.46 $276K 2,528,025
2023-06-26 BENTSUR RON Chairman & CEO Purchase +750 $16.50 $12K 3,230,779
2023-06-23 Mosseri Marlio Charles 10% owner Purchase +73,175 $17.43 $1.3M 2,511,265
2023-06-22 Mosseri Marlio Charles 10% owner Purchase +6,999 $17.73 $124K 2,438,090
2023-06-21 Mosseri Marlio Charles 10% owner Purchase +6,091 $17.71 $108K 2,431,091
2023-06-21 BENTSUR RON Chairman & CEO Purchase +500 $17.88 $9K 3,230,029
2023-06-16 Mosseri Marlio Charles 10% owner Purchase +12,700 $17.75 $225K 2,425,000
2023-06-16 Oliviero James F III Director Grant or award +18,000 27,828
2023-06-16 Kaplan Matthew L. Director Grant or award +18,000 53,760
2023-06-16 Hoberman Kenneth Director Grant or award +18,000 73,140

Page 5 of 7 · 136 trades